◆ Notable findingA finding from a controlled trial, systematic review, or meta-analysis with noteworthy results.Systematic ReviewSummary and analysis of existing published studies.Published: March 24, 2026
Sevoflurane May Help Reduce Pain in Chronic Wounds
Researchers studied the use of sevoflurane as a local analgesic for managing pain in chronic or hard-to-heal wounds. They found that sevoflurane may reduce pain within minutes and last for hours, with minimal reported side effects. However, more research is needed to confirm its safety and effectiveness.
Why it matters: Understanding the potential benefits of sevoflurane for wound pain management could lead to improved treatment options for people with chronic wounds.
The review is based on 21 studies, but more high-quality research is needed to solidify the efficacy and safety of topically administered sevoflurane. The studies included various types, but the review did not specify the sample size or duration of the studies.
Small Human StudySmall or uncontrolled human study. Results are preliminary.Published: March 19, 2026
Rare Skin Infection May Spread to Other Areas
Researchers reported a case of a rare skin infection caused by a fungus called Trichophyton rubrum. This fungus is usually harmless but can cause problems in people with weakened immune systems. In this case, the infection spread to other areas of the body and caused multiple ulcers and abscesses.
Why it matters: This case study may help dermatologists better understand how this rare infection can progress and how to treat it.
This study is a case report and involved a single patient, so the findings may not be representative of all cases. The patient had a history of immunosuppression, which may have contributed to the severity of the infection.
◆ Notable findingA finding from a controlled trial, systematic review, or meta-analysis with noteworthy results.Controlled TrialControlled human study, often randomized. Stronger evidence.Published: March 19, 2026
Tirbanibulin 1% May Help Treat Actinic Keratosis
A small study in Spain and Italy looked at how well tirbanibulin 1% worked for patients with actinic keratosis, a skin condition often caused by sun exposure. Researchers found that patients and doctors were generally satisfied with the treatment and reported good results. However, more research is needed to confirm these findings.
Why it matters: This study may help us better understand how to treat actinic keratosis, a common skin condition that can be a sign of skin cancer.
This study was conducted in a small group of patients (n=328) in Spain and Italy, and the results may not be generalizable to other populations. The study had a short duration of 57 days, and more research is needed to confirm the long-term effectiveness and safety of tirbanibulin 1%.
Animal StudyResults in animals only. May or may not translate to humans.Published: March 13, 2026
Frankincense Oil Extract May Help Reduce Psoriasis Symptoms
Researchers studied the effects of frankincense oil extract on psoriasis-like dermatitis in mice. They found that it may help reduce symptoms such as desquamation, erythema, and epidermal thickening. The extract's anti-inflammatory and skin barrier-protective effects were also observed.
Why it matters: This study may contribute to a better understanding of how to manage psoriasis symptoms and potentially lead to new treatment options.
This study was conducted in mice and its findings may not translate directly to humans. Further research is needed to confirm these results.
Animal StudyResults in animals only. May or may not translate to humans.Published: March 13, 2026
Mahoniae Caulis may help reduce inflammation in acute mastitis
Researchers studied the traditional Chinese medicine Mahoniae Caulis to see if it could help treat acute mastitis, a painful breast inflammation. They found that it may reduce inflammation by inhibiting a specific signaling pathway. However, more research is needed to confirm these findings.
Why it matters: This study may help us understand how certain natural remedies can be used to treat breast inflammation, which could lead to new treatment options.
This study was conducted in a lab using a mouse model and has not been tested in humans. Further research is needed to confirm its effectiveness and safety in people.
◆ Notable findingA finding from a controlled trial, systematic review, or meta-analysis with noteworthy results.Controlled TrialControlled human study, often randomized. Stronger evidence.Published: March 4, 2026
Combining laser and ivermectin cream may help reduce rosacea redness
Researchers studied whether adding ivermectin cream to laser treatment for rosacea can improve results. A small study found that combining these treatments may help reduce redness in rosacea. However, the study only looked at a short period of time and more research is needed to confirm these findings.
Why it matters: This study may help skincare professionals understand how to better treat rosacea, a common skin condition characterized by redness and inflammation.
This study had a small sample size of 24 patients and only looked at the effects of treatment over a short period of 16 weeks.
Animal StudyResults in animals only. May or may not translate to humans.Published: March 1, 2026
New Long-Acting Pain Relief Formulation Studied in Mice
Researchers studied a new extended-release pain relief formulation called Bup ER in mice to see how well it worked and how long it lasted. They found that it provided effective pain relief for up to 96 hours and had a long-lasting effect in the mice's plasma. However, more studies are needed to confirm these findings.
Why it matters: This study may help inform the development of new pain relief treatments for animals, which could potentially lead to advancements in human pain management.
This study was conducted in mice and has not been tested in humans. The formulation was administered subcutaneously, and some mice developed skin ulcerations due to improper injection technique.
◆ Notable findingA finding from a controlled trial, systematic review, or meta-analysis with noteworthy results.Controlled TrialControlled human study, often randomized. Stronger evidence.Published: February 10, 2026
Combination Treatment May Help Erythematotelangiectatic Rosacea
Researchers studied a combination treatment of oral doxycycline, topical calcineurin inhibitor, and pulsed dye laser for erythematotelangiectatic rosacea. They found that this treatment may improve erythema, especially in patients with moderate-to-severe cases. However, more research is needed to confirm these findings.
Why it matters: Understanding effective treatments for erythematotelangiectatic rosacea may help individuals manage their condition and improve their quality of life.
This study had a relatively small sample size of 79 patients and focused on a specific subtype of rosacea. Further research is needed to confirm these findings and explore their generalizability.
◆ Notable findingA finding from a controlled trial, systematic review, or meta-analysis with noteworthy results.Systematic ReviewSummary and analysis of existing published studies.Published: February 1, 2026
Understanding and Treating Impetigo: A Review of Current Research
Researchers reviewed evidence on impetigo, a common skin infection in children, to understand its causes, symptoms, and treatment options. Impetigo is often caused by bacteria and can be treated with topical or oral antibiotics. Good hygiene and avoiding crowded living environments may help reduce the spread of impetigo.
Why it matters: Understanding impetigo and its treatment options may help parents and caregivers manage this common skin infection in children.
This review is based on existing research and does not include new findings. The review's conclusions are based on a comprehensive analysis of existing studies, but the quality and consistency of the evidence may vary.
◆ Notable findingA finding from a controlled trial, systematic review, or meta-analysis with noteworthy results.Controlled TrialControlled human study, often randomized. Stronger evidence.Published: February 1, 2026
Topical Gel and Red Light May Help Treat Facial Skin Cancer
A small study looked at using a topical gel and red light to treat a type of skin cancer called cutaneous squamous cell carcinoma in situ on the face. Researchers found that this treatment was effective in clearing the cancer in all 20 patients studied. The treatment was also found to be safe and well-tolerated.
Why it matters: This study may help skincare understanding by providing a new, non-invasive treatment option for facial skin cancer.
This study had a small sample size of 20 patients and was limited to facial skin cancer in situ.
◆ Notable findingA finding from a controlled trial, systematic review, or meta-analysis with noteworthy results.Controlled TrialControlled human study, often randomized. Stronger evidence.Lactic AcidPublished: February 1, 2026
New topical solution may help treat mild nail fungus
Researchers studied a new topical solution for treating mild nail fungus. The solution was applied twice daily for six months to 50 adult subjects. After three months, 80% of participants had negative mycological results, and after six months, 50% were completely cured.
Why it matters: This study may help address the need for safer and more effective treatments for nail fungus.
This study had a small sample size of 50 participants and was open-label, meaning the researchers knew which treatment the participants were receiving.
Small Human StudySmall or uncontrolled human study. Results are preliminary.Published: February 1, 2026
Intense Pulsed Light May Help with Severe Allergic Eye Irritation
A small study looked at whether intense pulsed light can help people with severe allergic eye irritation. Researchers found that it may improve symptoms, but more research is needed to confirm this. The study also found changes in tear fluid that may be related to the treatment's effects.
Why it matters: This study may help us understand how intense pulsed light affects the eyes and could lead to new treatments for allergic eye irritation.
This study had a small sample size of 18 patients and was a single-arm interventional study, meaning it only looked at the effects of intense pulsed light and not a comparison group.